SLXP Related Analyst Ratings
-
Wells Fargo Maintains a 'Market Perform' on Salix Pharmaceuticals (SLXP); Raises Valuation Range
-
JMP Securities Initiates Coverage on Salix Pharmaceuticals (SLXP) with a Market Outperform
-
Wedbush Morgan Upgrades Salix Pharmaceuticals (SLXP) to Outperform
-
Piper Jaffray Maintains an 'Overweight' Rating on Salix Pharmaceuticals (SLXP); Raises Price Target
-
Merriman Curhan Initiates Coverage on Salix Pharmaceutical (SLXP) with a Buy
-
Piper Jaffray Initiates Coverage on Salix Pharmaceuticals (SLXP) with an Overweight
-
Credit Suisse Upgrades Salix (Nasdaq: SLXP) to Outperform
-
Roth Capital Upgrades Salix Pharmaceuticals (SLXP) to Buy
-
Caris Starts Salix Pharma (SLXP) at Buy
-
Matrix Lighthouse Rating Changes 11/03
-
Matrix USA Rating Changes 8/15
-
Roth Capital Downgrades Salix Pharmaceuticals Ltd. (SLXP) to Hold
-
Matrix USA Rating Changes 5/21
-
Matrix USA Rating Changes 5/13
-
Credit Suisse Initiates Coverage on Salix Pharma (SLXP) with a Neutral
-
Piper Jaffray Downgrades Salix Pharmaceuticals (SLXP) to Sell
-
Matrix USA Rating Changes 11/15
-
BMO Capital Starts Salix Pharm (SLXP) at Market Perform
-
William Blair downgrades SLXP to Market Perform
-
CE Unterberg highlights SLXP as a Top 1Q06 Pick
-
Roth Capital Downgraded SLXP
-
SunTrust Upgrades SLXP to Buy
Back to SLXP Stock Lookup
